Maximus Stock Forecast, Price & News

-0.63 (-0.69 %)
(As of 06/23/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume190,936 shs
Average Volume326,331 shs
Market Capitalization$5.61 billion
P/E Ratio20.82
Dividend Yield1.22%
30 days | 90 days | 365 days | Advanced Chart
Receive MMS News and Ratings via Email

Sign-up to receive the latest news and ratings for Maximus and its competitors with MarketBeat's FREE daily newsletter.

Maximus logo

About Maximus

Maximus, Inc. provides business process services (BPS) to government health and human services programs worldwide. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers various BPS solutions, such as program administration, appeals and assessments, and related consulting works for U.S. state and local government programs, including the Affordable Care Act, Medicaid, the Children's Health Insurance Program, Temporary Assistance to Needy Families, child support programs, Preadmission Screening and Resident Reviews, and Independent Developmental Disability assessments. This segment also provides program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; person-centered independent disability, long-term sick, and other health assessments; and specialized consulting services. The U.S. Federal Services segment offers centralized citizen engagement centers and support services; document and record management; case management, citizen support, and consumer education; independent medical reviews and worker's compensation benefit appeals; Medicare and Medicaid appeals; and federal marketplace eligibility appeals. This segment also provides modernization of systems and information technology infrastructure; infrastructure operations and support services; software development, operations, and management services; and data analytics services. The Outside the U.S. segment offers BPS solutions for governments and commercial clients outside the United States, including health and disability assessments, program administration for employment services, and other job seeker-related services. The company was founded in 1975 and is headquartered in Reston, Virginia.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

1.84 out of 5 stars

Business Services Sector

65th out of 505 stocks

Business Services, Not Elsewhere Classified Industry

32nd out of 204 stocks

Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Maximus (NYSE:MMS) Frequently Asked Questions

Is Maximus a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Maximus in the last twelve months. There are currently 1 hold rating, 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Maximus stock.
View analyst ratings for Maximus
or view top-rated stocks.

What stocks does MarketBeat like better than Maximus?

Wall Street analysts have given Maximus a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Maximus wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Maximus' next earnings date?

Maximus is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Maximus

How were Maximus' earnings last quarter?

Maximus, Inc. (NYSE:MMS) released its quarterly earnings data on Thursday, May, 6th. The health services provider reported $1.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.82 by $0.47. The health services provider had revenue of $959.30 million for the quarter, compared to analyst estimates of $846.71 million. Maximus had a trailing twelve-month return on equity of 21.38% and a net margin of 7.31%. The firm's quarterly revenue was up 17.3% on a year-over-year basis. During the same quarter last year, the business earned $0.82 EPS.
View Maximus' earnings history

How has Maximus' stock price been impacted by Coronavirus (COVID-19)?

Maximus' stock was trading at $60.94 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MMS stock has increased by 49.7% and is now trading at $91.21.
View which stocks have been most impacted by COVID-19

How often does Maximus pay dividends? What is the dividend yield for Maximus?

Maximus announced a quarterly dividend on Thursday, April 15th. Stockholders of record on Friday, May 14th will be given a dividend of $0.28 per share on Friday, May 28th. This represents a $1.12 annualized dividend and a dividend yield of 1.23%. The ex-dividend date is Thursday, May 13th.
View Maximus' dividend history

Is Maximus a good dividend stock?

Maximus pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.22%. Maximus does not yet have a strong track record of dividend growth. The dividend payout ratio of Maximus is 33.04%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Maximus will have a dividend payout ratio of 24.45% next year. This indicates that Maximus will be able to sustain or increase its dividend.
View Maximus' dividend history.

What guidance has Maximus issued on next quarter's earnings?

Maximus issued an update on its FY 2021 earnings guidance on Thursday, May, 27th. The company provided earnings per share (EPS) guidance of 4.200-4.400 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.650. The company issued revenue guidance of $4 billion-$4.20 billion, compared to the consensus revenue estimate of $3.63 billion.

What price target have analysts set for MMS?

3 brokerages have issued twelve-month price objectives for Maximus' stock. Their forecasts range from $84.00 to $110.00. On average, they expect Maximus' share price to reach $96.33 in the next year. This suggests a possible upside of 5.6% from the stock's current price.
View analysts' price targets for Maximus
or view top-rated stocks among Wall Street analysts.

Who are Maximus' key executives?

Maximus' management team includes the following people:
  • Mr. Bruce L. Caswell, Pres, CEO & Director (Age 54, Pay $1.74M)
  • Mr. Richard J. Nadeau, CFO & Treasurer (Age 66, Pay $879.77k)
  • Mr. David R. Francis, Gen. Counsel & Sec. (Age 60, Pay $662.05k)
  • Mr. Thomas Romeo, Gen. Mang. of US Federal Services Segment
  • Mr. John Lambeth, Chief Information Officer
  • Mr. Jericho Seguin, Sr. VP of Corp. Devel.
  • Ms. Michelle F. Link, Chief HR Officer (Age 46)
  • Ms. Rebecca Kenawell, Sr. VP of HR
  • Mr. David A. Casey, Sr. VP of Gov. Relations & Bus. Devel. (Age 61)
  • Ms. Deborah Homewood, Managing Director of Human Services - Australia

What is Bruce Caswell's approval rating as Maximus' CEO?

145 employees have rated Maximus CEO Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among Maximus' employees.

Who are some of Maximus' key competitors?

What other stocks do shareholders of Maximus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), The Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

What is Maximus' stock symbol?

Maximus trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

Who are Maximus' major shareholders?

Maximus' stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (13.31%), Victory Capital Management Inc. (6.41%), Alliancebernstein L.P. (4.40%), Mondrian Investment Partners LTD (1.95%), Geode Capital Management LLC (1.82%) and Janus Henderson Group PLC (1.77%). Company insiders that own Maximus stock include Bruce Caswell, David Francis, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo.
View institutional ownership trends for Maximus

Which institutional investors are selling Maximus stock?

MMS stock was sold by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Lord Abbett & CO. LLC, Man Group plc, Renaissance Technologies LLC, Acadian Asset Management LLC, Cubist Systematic Strategies LLC, D. E. Shaw & Co. Inc., and UBS Asset Management Americas Inc.. Company insiders that have sold Maximus company stock in the last year include Bruce Caswell, David Francis, Raymond B Ruddy, Richard A Montoni, and Thomas D Romeo.
View insider buying and selling activity for Maximus
or view top insider-selling stocks.

Which institutional investors are buying Maximus stock?

MMS stock was acquired by a variety of institutional investors in the last quarter, including Oak Ridge Investments LLC, BlackRock Inc., Prudential Financial Inc., Brown Advisory Inc., Victory Capital Management Inc., Geode Capital Management LLC, Janus Henderson Group PLC, and Pier Capital LLC.
View insider buying and selling activity for Maximus
or or view top insider-buying stocks.

How do I buy shares of Maximus?

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Maximus' stock price today?

One share of MMS stock can currently be purchased for approximately $91.21.

How much money does Maximus make?

Maximus has a market capitalization of $5.61 billion and generates $3.46 billion in revenue each year. The health services provider earns $214.51 million in net income (profit) each year or $3.39 on an earnings per share basis.

How many employees does Maximus have?

Maximus employs 34,300 workers across the globe.

When was Maximus founded?

Maximus was founded in 1975.

What is Maximus' official website?

The official website for Maximus is www.maximus.com.

Where are Maximus' headquarters?

Maximus is headquartered at 1891 METRO CENTER DRIVE, RESTON VA, 20190.

How can I contact Maximus?

Maximus' mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]

This page was last updated on 6/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.